Related Experiment Videos
Structure-activity relationships for the mutagenic activity of tricyclic intercalating agents in Salmonella
W A Denny1, P M Turner, G J Atwell
1Cancer Research Laboratory, University of Auckland School of Medicine, New Zealand.
Abstract:
A total of 25 different tricyclic DNA-intercalating chromophores bearing a common -CONH(CH2)2N(CH3)2 solubilizing sidechain have been compared with the 'classical' frameshift mutagen 9-aminoacridine for their ability to induce revertants in Salmonella typhimurium strain TA1537 (sensitive to frameshift mutation by acridine mutagens). The compounds showed varying levels of activity in this strain. For the fused linear and fused angular tricyclics, activity varied from zero to similar levels to 9-aminoacridine, but with no discernable relationship between activity and either structure or the measured physico-chemical properties. However, the '2-1' tricyclic compounds had essentially no mutagenic activity. Since several of these compounds have high in vivo antitumor activity, this is useful knowledge.
Insights
Researchers compared 25 tricyclic DNA-intercalating compounds to 9-aminoacridine for mutagenicity in Salmonella typhimurium. Some tricyclics showed mutagenic activity, while
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Genetics
Background:
- Tricyclic DNA-intercalating agents are investigated for potential therapeutic applications.
- Understanding structure-activity relationships is crucial for drug development.
- Frameshift mutagens like 9-aminoacridine serve as benchmarks for mutagenicity testing.
Purpose of the Study:
- To evaluate the mutagenic potential of 25 novel tricyclic DNA-intercalating chromophores.
- To compare the mutagenicity of these compounds with the known frameshift mutagen 9-aminoacridine.
- To explore potential correlations between chemical structure, physicochemical properties, and mutagenic activity.
Main Methods:
- Bacterial reverse mutation assay using Salmonella typhimurium strain TA1537.
- Synthesis and characterization of 25 tricyclic DNA-intercalating chromophores with a common sidechain.
- Comparison of mutagenic activity across different tricyclic structural classes (fused linear, fused angular, '2-1').
Main Results:
- Mutagenic activity varied among the tested tricyclic compounds.
- Fused linear and angular tricyclics exhibited activity ranging from none to levels comparable to 9-aminoacridine.
- No clear relationship was observed between the mutagenic activity of these compounds and their structure or physicochemical properties.
- The '2-1' tricyclic compounds demonstrated negligible mutagenic activity.
Conclusions:
- The mutagenic potential of tricyclic DNA-intercalating agents is structure-dependent.
- Certain tricyclic structures may be devoid of mutagenic activity, despite DNA-intercalating properties.
- This finding is significant given that several of these compounds possess high in vivo antitumor activity, suggesting a potential for therapeutic use without significant genotoxic risk.